"The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to Addyi’s approval, there were no FDA-approved treatments for se"...
(Generic versions may still be available.)
Cefizox® (ceftizoxime for injection, USP) is a sterile, semisynthetic, broad-spectrum, betalactamase resistant cephalosporin antibiotic for parenteral (IV, IM) administration. It is the sodium salt of [6R-[6a,7B(Z)]]-7-[(2,3-dihydro-2-imino-4-thiazolyl) (methoxyimino)acetyl]amino]- 8-oxo-5-thia-i-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Its sodium content is approximately 60 mg (2.6 mEq) per gram of ceftizoxime activity.
It has the following molecular formula: C13H12N5NaO5S2 and its molecular weight is 405.38.
Ceftizoxime for injection, USP is a white to pale yellow crystalline powder. Cefizox (ceftizoxime) is supplied in vials equivalent to 500 mg, 1 gram or 2 grams of ceftizoxime, and in Piggyback Vials for IV admixture equivalent to 1 gram or 2 grams of ceftizoxime.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Cefizox Information
- Cefizox Drug Interactions Center: ceftizoxime inj
- Cefizox Side Effects Center
- Cefizox FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Sex & Relationships
Get tips to boost your love life.